TVM V LIFE SCIENCE VENTURES GMBH & CO KG's Net Worth

$58.5 Million

Estimate Recalculated Sep 8, 2024 07:27PM EST

Who is TVM V LIFE SCIENCE VENTURES GMBH & CO KG?

TVM V LIFE SCIENCE VENTURES GMBH & CO KG has an estimated net worth of $58.5 Million. This is based on reported shares across multiple companies, which include ENANTA PHARMACEUTICALS INC, Sirtris Pharmaceuticals, Inc., Coley Pharmaceutical Group, Inc., bluebird bio, Inc., Pharmasset Inc, and ARGOS THERAPEUTICS INC.

SEC CIK

TVM V LIFE SCIENCE VENTURES GMBH & CO KG's CIK is 0001183073

Past Insider Trading and Trends

2013 was TVM V LIFE SCIENCE VENTURES GMBH & CO KG's most active year for acquiring shares with 15 total transactions. TVM V LIFE SCIENCE VENTURES GMBH & CO KG's most active month to acquire stocks was the month of May. 2014 was TVM V LIFE SCIENCE VENTURES GMBH & CO KG's most active year for disposing of shares, totalling 27 transactions. TVM V LIFE SCIENCE VENTURES GMBH & CO KG's most active month to dispose stocks was the month of February. 2013 saw TVM V LIFE SCIENCE VENTURES GMBH & CO KG paying a total of $1,861,286.00 for 4,963,752 shares, this is the most they've acquired in one year. In 2014 TVM V LIFE SCIENCE VENTURES GMBH & CO KG cashed out on 1,179,335 shares for a total of $45,914,359.87, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ENANTA PHARMACEUTICALS INC (ENTA) Snapshot price: $11.54

Investor

TVM V LIFE SCIENCE VENTURES GMBH & CO KG owns 1,144,932 units of Common Stock which is worth $13,212,515.28. In the year 2014 TVM V LIFE SCIENCE VENTURES GMBH & CO KG filed a total of 7 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
-9.86%
-439.33K
$38.82
-$17,053,133.96
4.01M
Mar 3 - Mar 4
Form 4
-9.64%
-439.33K
$38.82
-$17,053,133.96
4.12M
Mar 3 - Mar 4
Form 4
-4.74%
-230.19K
$39.43
-$9,012,968.30
4.62M
Feb 25 - Feb 26
Form 4
-1.20%
-60.48K
$39.75
-$2,393,270.65
4.98M
Feb 21 - Feb 24
Form 4
-0.39%
-10.00K
$40.19
-$401,853.00
2.52M
Feb 18
Form 4
+431.31%
2.53M
$14.00
—
3.12M
Mar 26
Form 3
—
0
—
—
0
No matching records found

Sirtris Pharmaceuticals, Inc. No price found

Investor

TVM V LIFE SCIENCE VENTURES GMBH & CO KG owns 2,577,435 units of Common Stock. In the year 2007 TVM V LIFE SCIENCE VENTURES GMBH & CO KG filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.58M
—
—
2.58M
May 29
Form 3
—
0
—
—
0
No matching records found

Coley Pharmaceutical Group, Inc. No price found

Investor

TVM V LIFE SCIENCE VENTURES GMBH & CO KG owns 1,960,735 units of Common Stock. In the year 2005 TVM V LIFE SCIENCE VENTURES GMBH & CO KG filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.96M
—
—
1.96M
Aug 15
Form 3
—
0
—
—
0
No matching records found

bluebird bio, Inc. (BLUE) Snapshot price: $0.53

Investor

TVM V LIFE SCIENCE VENTURES GMBH & CO KG owns 2,254,357 units of Common Stock which is worth $1,194,809.21. In the year 2013 TVM V LIFE SCIENCE VENTURES GMBH & CO KG filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.25M
—
—
2.25M
Jun 24
Form 3
—
0
—
—
0
No matching records found

Pharmasset Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found